Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT02954510
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
185
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
ferumoxytol
Sponsor
Brigham and Women's Hospital